KROS (kerostx.com) Prakiraan pendapatan perusahaan

Keros Therapeutics Inc - logo grafis emiten KROS

Keros Therapeutics (KROS) relies on capital from major shareholders due to a lack of current sales. Financial stability is constrained by a costly testing period and competition within the hematology sector. This future sales volume chart reflects demand dynamics, where the current value equals 0.04. Growth prospects are tied to the development of pulmonary hypertension therapy and potential leadership in the tissue regulation niche.

KROS - Pendapatan mangsa ngarep perusahaan Keros Corp ing rentang 04.07.2022 - 18.11.2026

Rincian metrik keuangan lan pasar Keros Corp (KROS)

- indikator valuasi pasar bisnis:
Analisis fundamental perusahaan:kerostx.com
Produk mawa merek Keros Pharma

This indicator measures market expectations for future cash flows by analyzing resource procurement and supply chain resilience to determine business expansion potential. The trend in prospective sales reflects the operational reliability of Keros Therapeutics (KROS), demonstrating the infrastructure's readiness to scale therapies for rare blood and bone pathologies through insurance fund payments.

Analisis perusahaan pesaing

Volume dodolan mangsa ngarep perusahaan VRTX (Vertex)|ALNY (Alnylam Pharmaceuticals, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Insmed INSM|UTHR (United Therapeutics Corp.) - Pendapatan sing dikarepake perusahaan|BioMarin Pharmaceutical - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan BBIO (BridgeBio Pharma, Inc.)|BGM Group Corp (BGM) - Prakiraan pendapatan perusahaan|Cogent Biosciences Inc (COGT) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan Xeris Biopharma Inc|ARCT: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan etonpharma.com (ETON)|Volume dodolan mangsa ngarep perusahaan Kamada Ltd. KMDA|Prakiraan volume dodolan FULC (fulcrumtx.com)|Prakiraan volume dodolan Abeona ABEO|MREO - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan PLX (Protalix BioTherapeutics, Inc)|Pliant Therapeutics Inc (PLRX) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan APLT (appliedtherapeutics.com)|RNTX (Rein Therapeutics Inc.) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GELS|Volume dodolan mangsa ngarep perusahaan AYTU (aytubio.com)|Volume dodolan mangsa ngarep perusahaan Chemomab Therapeutics Ltd CMMB|Prakiraan volume dodolan SRXH (SRx Health Solutions Inc.)|Pendapatan mangsa ngarep perusahaan PLRZ|AEZS - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan CYTH (CTD Holdings)|INZY: Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan RPHM (Reneo Pharma)|Prakiraan pendapatan perusahaan cosciensbio.com